CYLD in Ubiquitin Signaling and Tumor Pathogenesis

Fumiyo Ikeda; Ivan Dikic

doi:10.1016/j.cell.2006.05.003

CYLD in Ubiquitin Signaling and Tumor Pathogenesis

Fumiyo Ikeda, Ivan Dikic

Research output: Contribution to journal › Short survey › peer-review

24 Citations (Scopus)

Abstract

Absence of CYLD, which encodes a deubiquitinating enzyme, causes an inherited disease characterized by benign skin tumors. In this issue of Cell, Massoumi et al. (2006) show that CYLD deubiquitinates the coactivator Bcl-3, thereby preventing its translocation into the nucleus, where it normally interacts with NF-κB and activates transcription of proliferation genes in response to growth signals.

Original language	English
Pages (from-to)	643-645
Number of pages	3
Journal	Cell
Volume	125
Issue number	4
DOIs	https://doi.org/10.1016/j.cell.2006.05.003
Publication status	Published - May 19 2006
Externally published	Yes

All Science Journal Classification (ASJC) codes

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1016/j.cell.2006.05.003

Cite this

@article{3700abc66c104e0f833e75804d198697,

title = "CYLD in Ubiquitin Signaling and Tumor Pathogenesis",

abstract = "Absence of CYLD, which encodes a deubiquitinating enzyme, causes an inherited disease characterized by benign skin tumors. In this issue of Cell, Massoumi et al. (2006) show that CYLD deubiquitinates the coactivator Bcl-3, thereby preventing its translocation into the nucleus, where it normally interacts with NF-κB and activates transcription of proliferation genes in response to growth signals.",

author = "Fumiyo Ikeda and Ivan Dikic",

year = "2006",

month = may,

day = "19",

doi = "10.1016/j.cell.2006.05.003",

language = "English",

volume = "125",

pages = "643--645",

journal = "Cell",

issn = "0092-8674",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - CYLD in Ubiquitin Signaling and Tumor Pathogenesis

AU - Ikeda, Fumiyo

AU - Dikic, Ivan

PY - 2006/5/19

Y1 - 2006/5/19

N2 - Absence of CYLD, which encodes a deubiquitinating enzyme, causes an inherited disease characterized by benign skin tumors. In this issue of Cell, Massoumi et al. (2006) show that CYLD deubiquitinates the coactivator Bcl-3, thereby preventing its translocation into the nucleus, where it normally interacts with NF-κB and activates transcription of proliferation genes in response to growth signals.

AB - Absence of CYLD, which encodes a deubiquitinating enzyme, causes an inherited disease characterized by benign skin tumors. In this issue of Cell, Massoumi et al. (2006) show that CYLD deubiquitinates the coactivator Bcl-3, thereby preventing its translocation into the nucleus, where it normally interacts with NF-κB and activates transcription of proliferation genes in response to growth signals.

UR - http://www.scopus.com/inward/record.url?scp=33646529360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646529360&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2006.05.003

DO - 10.1016/j.cell.2006.05.003

M3 - Short survey

C2 - 16713556

AN - SCOPUS:33646529360

VL - 125

SP - 643

EP - 645

JO - Cell

JF - Cell

SN - 0092-8674

IS - 4

ER -

CYLD in Ubiquitin Signaling and Tumor Pathogenesis

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this